BSX Boston Scientific Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: BSX
  4. Earnings
?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 75
Relative Profitability: Rel. Profitability: 91

EPS in 2026 (TTM): $2.41

Last Report Period Date: Mar 31, 2026

Currently, BSX's 12-month EPS stands at $2.41, according to the most recent financial reports. Boston Scientific's earnings per share in 2025 was reported at $1.96, marking a rise from $1.26 in 2024. BSX recorded an EPS of $0.9 for the quarterly period ending on Mar 31, 2026.

BSX earnings history

Historical annual and quarterly earnings per share (EPS) data for Boston Scientific
EPS (TTM)
$2.41
EPS Growth YoY (Quarterly)
95.7%
EPS (Quarterly)
$0.9
EPS Growth (Quarterly)
95.7%

In 2025, Boston Scientific's earnings per share was $1.96, a rise of 55.6% from $1.26 in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $0.9, showing a 95.7% increase compared to the same quarter last year. The trailing twelve months EPS for BSX is $2.41 as of March 2026. Boston Scientific's full-year EPS for 2024 was $1.26, a 16.7% rise compared to the previous year.

BSX earnings chart

BSX EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
95.7%
EPS growth YoY
55.6%
EPS growth 3Y avg
63.3%
EPS growth 5Y avg
N/A

Over the past 12 months, Boston Scientific has recorded an earnings per share growth rate of 95.7% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 63.3% per year for the last 3 years.

BSX Earnings Waterfall

Breakdown of revenue, profit and net income for Boston Scientific

BSX Earnings vs Peers

What are the earnings of BSX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
CNMD CONMED Corp 18.38 -64.6% N/A 35.7%
BSX Boston Scientific Corp 18.46 55.6% 63.3% N/A
MDT Medtronic plc 21.23 3.3% 9.8% 6.9%
MMSI Merit Medical Systems Inc 28.34 4.8% 18.3% N/A
SYK Stryker Corp 34.78 8% 10.9% 14.8%
EW Edwards Lifesciences Corp 45.17 -73.6% -9.2% 6.9%
TFX Teleflex Inc N/A -1,462.4% N/A N/A
ANGO Angiodynamics Inc N/A 81.9% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.